Objective To summarize the classic and latest treatment techniques for localized knee cartilage lesions in clinical practice and create a new comprehensive clinical decision-making process. Methods The advantages and limitations of various treatment methods for localized knee cartilage lesions were summarized by extensive review of relevant literature at home and abroad in recent years. Results Currently, there are various surgical methods for treating localized knee cartilage injuries in clinical practice, each with its own pros and cons. For patients with cartilage injuries less than 2 cm2 and 2-4 cm2 with bone loss are recommended to undergo osteochondral autograft (OAT) and osteochondral allograft (OCA) surgeries. For patients with cartilage injuries less than 2 cm2 and 2-4 cm2 without bone loss had treatment options including bone marrow-based techniques (micro-fracture and ogous matrix induced chondrogenesis), autologous chondrocyte implantation (ACI)/matrix-induced ACI, particulated juvenile allograft cartilage (PJAC), OAT, and OCA. For patients with cartilage injuries larger than 4 cm2 with bone loss were recommended to undergo OCA. For patients with cartilage injuries larger than 4 cm2 without bone loss, treatment options included ACI/matrix-induced ACI, OAT, and PJAC. Conclusion There are many treatment techniques available for localized knee cartilage lesions. Treatment strategy selection should be based on the size and location of the lesion, the extent of involvement of the subchondral bone, and the level of evidence supporting each technique in the literature.
Citation:
TIAN Guangzhao, LI Runmeng, YANG Yongkang, NING Chao, GUO Quanyi. Advances in clinical repair techniques for localized knee cartilage lesions. Chinese Journal of Reparative and Reconstructive Surgery, 2024, 38(7): 889-895. doi: 10.7507/1002-1892.202402056
Copy
Copyright © the editorial department of Chinese Journal of Reparative and Reconstructive Surgery of West China Medical Publisher. All rights reserved
1. |
|
2. |
|
3. |
|
4. |
Ren Z, Liu Y, Ma Y, et al. Treatment of articular cartilage defects: A descriptive analysis of clinical characteristics and global trends reported from 2001 to 2020. Cartilage, 2023.
|
5. |
|
6. |
|
7. |
|
8. |
|
9. |
|
10. |
|
11. |
|
12. |
|
13. |
|
14. |
|
15. |
|
16. |
Beer AJ, Tauro TM, Redondo ML, et al. Use of allografts in orthopaedic surgery: Safety, procurement, storage, and outcomes. Orthop J Sports Med, 2019, 7(12): 2325967119891435.
|
17. |
Weber AE, Locker PH, Mayer EN, et al. Clinical outcomes after microfracture of the knee: Midterm follow-up. Orthop J Sports Med, 2018, 6(2): 2325967117753572.
|
18. |
|
19. |
|
20. |
|
21. |
|
22. |
|
23. |
|
24. |
|
25. |
|
26. |
|
27. |
|
28. |
|
29. |
Mehta VM, Mehta S, Santoro S, et al. Short term clinical outcomes of a Prochondrix® thin laser-etched osteochondral allograft for the treatment of articular cartilage defects in the knee. J Orthop Surg (Hong Kong), 2022, 30(3): 10225536221141781.
|
30. |
|
31. |
|
32. |
|
33. |
|
34. |
|
35. |
Liang Y, Li J, Wang Y, et al. Platelet rich plasma in the repair of articular cartilage injury: A narrative review. Cartilage, 2022, 13(3): 19476035221118419.
|
36. |
Baird HBG, Ashy CC, Kodali P, et al. Most publications regarding platelet-rich plasma use in the knee are from Asia, investigate injection for osteoarthritis, and show outcome improvement: A scoping review. Arthroscopy, 2024.
|
37. |
Li M, Tu Y, Zhang H, et al. Effect of platelet-rich plasma scaffolding combined with osteochondral autograft transfer for full-thickness articular cartilage defects of the femoral condyle. Biomed Mater, 2022, 17(6).
|
38. |
|
39. |
|
40. |
|
- 1.
- 2.
- 3.
- 4. Ren Z, Liu Y, Ma Y, et al. Treatment of articular cartilage defects: A descriptive analysis of clinical characteristics and global trends reported from 2001 to 2020. Cartilage, 2023.
- 5.
- 6.
- 7.
- 8.
- 9.
- 10.
- 11.
- 12.
- 13.
- 14.
- 15.
- 16. Beer AJ, Tauro TM, Redondo ML, et al. Use of allografts in orthopaedic surgery: Safety, procurement, storage, and outcomes. Orthop J Sports Med, 2019, 7(12): 2325967119891435.
- 17. Weber AE, Locker PH, Mayer EN, et al. Clinical outcomes after microfracture of the knee: Midterm follow-up. Orthop J Sports Med, 2018, 6(2): 2325967117753572.
- 18.
- 19.
- 20.
- 21.
- 22.
- 23.
- 24.
- 25.
- 26.
- 27.
- 28.
- 29. Mehta VM, Mehta S, Santoro S, et al. Short term clinical outcomes of a Prochondrix® thin laser-etched osteochondral allograft for the treatment of articular cartilage defects in the knee. J Orthop Surg (Hong Kong), 2022, 30(3): 10225536221141781.
- 30.
- 31.
- 32.
- 33.
- 34.
- 35. Liang Y, Li J, Wang Y, et al. Platelet rich plasma in the repair of articular cartilage injury: A narrative review. Cartilage, 2022, 13(3): 19476035221118419.
- 36. Baird HBG, Ashy CC, Kodali P, et al. Most publications regarding platelet-rich plasma use in the knee are from Asia, investigate injection for osteoarthritis, and show outcome improvement: A scoping review. Arthroscopy, 2024.
- 37. Li M, Tu Y, Zhang H, et al. Effect of platelet-rich plasma scaffolding combined with osteochondral autograft transfer for full-thickness articular cartilage defects of the femoral condyle. Biomed Mater, 2022, 17(6).
- 38.
- 39.
- 40.